BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27184093)

  • 1. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
    Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
    BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
    Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
    Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
    N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
    Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
    BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
    Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
    Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
    J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence physician decision making for indeterminate pulmonary nodules.
    Vachani A; Tanner NT; Aggarwal J; Mathews C; Kearney P; Fang KC; Silvestri G; Diette GB
    Ann Am Thorac Soc; 2014 Dec; 11(10):1586-91. PubMed ID: 25386795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
    Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
    BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
    Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
    BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
    Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
    Respir Med; 2022; 204():106990. PubMed ID: 36283245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
    D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
    Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
    Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
    PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance of a bronchial genomic classifier.
    Hu Z; Whitney D; Anderson JR; Cao M; Ho C; Choi Y; Huang J; Frink R; Smith KP; Monroe R; Kennedy GC; Walsh PS
    BMC Cancer; 2016 Feb; 16():161. PubMed ID: 26920854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules.
    Vachani A; Hammoud Z; Springmeyer S; Cohen N; Nguyen D; Williamson C; Starnes S; Hunsucker S; Law S; Li XJ; Porter A; Kearney P
    Lung; 2015 Dec; 193(6):1023-7. PubMed ID: 26376647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a classifier combining bronchial transcriptomics and chest computed tomography features facilitates the diagnostic evaluation of lung cancer in smokers and nonsmokers.
    Xia Y; Ying S; Jin R; Wu H; Shen Y; Yin T; Yan F; Zhang W; Lan F; Zhang B; Zhu C; Li C; Li W; Shen H
    Int J Cancer; 2021 Sep; 149(6):1290-1301. PubMed ID: 33963762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy.
    Tournoy KG; Rintoul RC; van Meerbeeck JP; Carroll NR; Praet M; Buttery RC; van Kralingen KW; Rabe KF; Annema JT
    Lung Cancer; 2009 Jan; 63(1):45-9. PubMed ID: 18514365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm.
    Chhajed PN; Bernasconi M; Gambazzi F; Bubendorf L; Rasch H; Kneifel S; Tamm M
    Chest; 2005 Nov; 128(5):3558-64. PubMed ID: 16306037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions.
    van Boerdonk RA; Smesseim I; Heideman DA; Coupé VM; Tio D; Grünberg K; Thunnissen E; Snijders PJ; Postmus PE; Smit EF; Daniels JM; Sutedja TG
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1483-9. PubMed ID: 26275031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a prospective, multicenter, global, cohort study of electromagnetic navigation bronchoscopy.
    Folch EE; Bowling MR; Gildea TR; Hood KL; Murgu SD; Toloza EM; Wahidi MM; Williams T; Khandhar SJ
    BMC Pulm Med; 2016 Apr; 16(1):60. PubMed ID: 27113209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.